PDB Short entry for 3S3J HEADER TRANSFERASE/TRANSFERASE INHIBITOR 18-MAY-11 3S3J TITLE TRANSGLUTAMINASE 2 IN COMPLEX WITH A NOVEL INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 2-687; COMPND 5 SYNONYM: TISSUE TRANSGLUTAMINASE, TRANSGLUTAMINASE C, TG(C), TGC, COMPND 6 TGASE C, TRANSGLUTAMINASE H, TGASE H, TRANSGLUTAMINASE-2, TGASE-2; COMPND 7 EC: 2.3.2.13; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: PEPTIDE INHIBITOR; COMPND 11 CHAIN: B; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TGM2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 11 ORGANISM_TAXID: 32630 KEYWDS TRANSGLUTAMINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR I.LINDEMANN,A.HEINE,G.KLEBE REVDAT 5 15-NOV-23 3S3J 1 LINK ATOM REVDAT 4 13-SEP-23 3S3J 1 REMARK SEQADV LINK REVDAT 3 16-OCT-13 3S3J 1 LINK REVDAT 2 26-JUN-13 3S3J 1 REMARK REVDAT 1 06-JUN-12 3S3J 0 JRNL AUTH I.LINDEMANN,J.BOETTCHER,K.OERTEL,J.WEBER,M.HILS, JRNL AUTH 2 R.PASTERNACK,A.HEINE,G.KLEBE JRNL TITL INHIBITORS OF TRANSGLUTAMINASE 2: A THERAPEUTIC OPTION IN JRNL TITL 2 CELIAC DISEASE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7_650) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.90 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 90.4 REMARK 3 NUMBER OF REFLECTIONS : 37555 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.218 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 1886 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 24.8996 - 5.2663 0.89 2999 129 0.2110 0.2703 REMARK 3 2 5.2663 - 4.1865 0.85 2629 164 0.1691 0.2251 REMARK 3 3 4.1865 - 3.6592 0.89 2726 146 0.1869 0.2681 REMARK 3 4 3.6592 - 3.3255 0.90 2743 156 0.2137 0.2520 REMARK 3 5 3.3255 - 3.0876 0.91 2751 159 0.2350 0.3134 REMARK 3 6 3.0876 - 2.9058 0.93 2795 142 0.2493 0.3318 REMARK 3 7 2.9058 - 2.7605 0.93 2812 139 0.2383 0.2962 REMARK 3 8 2.7605 - 2.6405 0.95 2833 152 0.2292 0.3310 REMARK 3 9 2.6405 - 2.5389 0.95 2843 141 0.2410 0.3318 REMARK 3 10 2.5389 - 2.4514 0.94 2795 144 0.2555 0.3110 REMARK 3 11 2.4514 - 2.3748 0.92 2754 142 0.2604 0.3438 REMARK 3 12 2.3748 - 2.3070 0.89 2640 145 0.2758 0.3542 REMARK 3 13 2.3070 - 2.2463 0.80 2349 127 0.2791 0.3856 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.83 REMARK 3 K_SOL : 0.34 REMARK 3 B_SOL : 46.83 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.320 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.910 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.92120 REMARK 3 B22 (A**2) : 0.92120 REMARK 3 B33 (A**2) : -1.84240 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 5212 REMARK 3 ANGLE : 1.084 7097 REMARK 3 CHIRALITY : 0.070 795 REMARK 3 PLANARITY : 0.004 916 REMARK 3 DIHEDRAL : 15.150 1865 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3S3J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-MAY-11. REMARK 100 THE DEPOSITION ID IS D_1000065715. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-DEC-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR KMC REMARK 200 -2 REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-225 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38467 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09700 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.39200 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2Q3Z REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 3.0 M AMMONIUM SULFATE, 0.1 M HEPES, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K, PH 7.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 158.23050 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 36.23500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 36.23500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 79.11525 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 36.23500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 36.23500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 237.34575 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 36.23500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 36.23500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 79.11525 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 36.23500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 36.23500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 237.34575 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 158.23050 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE MAIN POLYMERIC PROTEIN-GLUTAMINE GAMMA- REMARK 300 GLUTAMYLTRANSFERASE 2 IS A MONOMER IN THE ABSENCE OF THE PEPTIDE REMARK 300 INHIBITOR REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE UNREACTED FORM OF THE PEPTIDE INHIBITOR, CHAIN B HAS A DIAZO REMARK 400 GROUP ATTACHED TO C25 OF THE AMINOACID 02Y. UPON REACTION WITH REMARK 400 PROTEIN, A COVALENT BOND BETWEEN C25 AND SG OF CYS 277 CHAIN A IS REMARK 400 FORMED REMARK 400 REMARK 400 THE N-[(BENZYLOXY)CARBONYL]-6-DIAZONIO-5-OXO-L-NORLEUCYL-L-VALYL-L- REMARK 400 PROLYL-L-LEUCINE IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: N-[(BENZYLOXY)CARBONYL]-6-DIAZONIO-5-OXO-L-NORLEUCYL-L- REMARK 400 VALYL-L-PROLYL-L-LEUCINE REMARK 400 CHAIN: B REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -6 REMARK 465 ALA A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 HIS A 0 REMARK 465 HIS A 1 REMARK 465 ASP A 306 REMARK 465 GLN A 307 REMARK 465 ASN A 308 REMARK 465 SER A 309 REMARK 465 GLU A 319 REMARK 465 PHE A 320 REMARK 465 GLY A 321 REMARK 465 GLU A 322 REMARK 465 ILE A 323 REMARK 465 GLN A 324 REMARK 465 GLY A 325 REMARK 465 ASP A 326 REMARK 465 LYS A 327 REMARK 465 GLN A 362 REMARK 465 GLU A 363 REMARK 465 LYS A 364 REMARK 465 SER A 365 REMARK 465 GLU A 366 REMARK 465 GLN A 407 REMARK 465 ASP A 408 REMARK 465 ASP A 409 REMARK 465 GLY A 410 REMARK 465 SER A 411 REMARK 465 VAL A 412 REMARK 465 HIS A 413 REMARK 465 LEU A 462 REMARK 465 ASN A 463 REMARK 465 LYS A 464 REMARK 465 LEU A 465 REMARK 465 ALA A 466 REMARK 465 GLU A 467 REMARK 465 LYS A 468 REMARK 465 GLU A 469 REMARK 465 GLU A 470 REMARK 465 PRO A 686 REMARK 465 ALA A 687 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 28 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 30 CG CD CE NZ REMARK 470 GLU A 70 CG CD OE1 OE2 REMARK 470 ASP A 97 CG OD1 OD2 REMARK 470 TYR A 125 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASN A 231 CG OD1 ND2 REMARK 470 ASP A 233 CG OD1 OD2 REMARK 470 GLN A 270 CG CD OE1 NE2 REMARK 470 ARG A 317 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 329 CG CD OE1 OE2 REMARK 470 TYR A 369 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ILE A 405 CG1 CG2 CD1 REMARK 470 LYS A 414 CG CD CE NZ REMARK 470 ARG A 418 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 456 CG CD1 CD2 CE1 CE2 CZ REMARK 470 SER A 482 OG REMARK 470 GLU A 557 CG CD OE1 OE2 REMARK 470 SER A 558 OG REMARK 470 LYS A 590 CG CD CE NZ REMARK 470 LYS A 598 CG CD CE NZ REMARK 470 GLN A 599 CG CD OE1 NE2 REMARK 470 LYS A 600 CG CD CE NZ REMARK 470 ARG A 601 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 602 CG CD CE NZ REMARK 470 LEU A 603 CG CD1 CD2 REMARK 470 GLU A 632 CG CD OE1 OE2 REMARK 470 LYS A 634 CG CD CE NZ REMARK 470 MET A 652 CG SD CE REMARK 470 LYS A 672 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 VAL B 279 C PRO B 280 N 0.145 REMARK 500 LEU B 281 C LEU B 281 O 0.143 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 28 -81.38 -60.87 REMARK 500 ALA A 66 62.73 -150.32 REMARK 500 GLN A 96 -158.56 -106.14 REMARK 500 ASN A 206 84.81 -163.12 REMARK 500 ARG A 214 5.06 -59.33 REMARK 500 CYS A 230 -75.77 -65.72 REMARK 500 ASN A 231 -89.13 56.36 REMARK 500 ASP A 233 -17.49 -28.39 REMARK 500 THR A 368 153.77 129.14 REMARK 500 ASP A 434 49.75 -79.62 REMARK 500 ALA A 459 -73.55 -64.85 REMARK 500 VAL A 479 -48.14 -136.28 REMARK 500 SER A 515 178.67 -59.82 REMARK 500 ASN A 517 3.42 -68.89 REMARK 500 GLN A 599 106.66 -49.73 REMARK 500 LEU A 657 -21.75 -142.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 703 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 704 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 705 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 706 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 707 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF PEPTIDE INHIBITOR REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2Q3Z RELATED DB: PDB REMARK 900 TRANSGLUTAMINASE 2 UNDERGOES LARGE CONFORMATIONAL CHANGE UPON REMARK 900 ACTIVATION REMARK 900 RELATED ID: 3S3P RELATED DB: PDB REMARK 900 RELATED ID: 3S3S RELATED DB: PDB DBREF 3S3J A 2 687 UNP P21980 TGM2_HUMAN 2 687 DBREF 3S3J B 277 281 PDB 3S3J 3S3J 277 281 SEQADV 3S3J MET A -6 UNP P21980 INITIATING METHIONINE SEQADV 3S3J ALA A -5 UNP P21980 EXPRESSION TAG SEQADV 3S3J HIS A -4 UNP P21980 EXPRESSION TAG SEQADV 3S3J HIS A -3 UNP P21980 EXPRESSION TAG SEQADV 3S3J HIS A -2 UNP P21980 EXPRESSION TAG SEQADV 3S3J HIS A -1 UNP P21980 EXPRESSION TAG SEQADV 3S3J HIS A 0 UNP P21980 EXPRESSION TAG SEQADV 3S3J HIS A 1 UNP P21980 EXPRESSION TAG SEQRES 1 A 694 MET ALA HIS HIS HIS HIS HIS HIS ALA GLU GLU LEU VAL SEQRES 2 A 694 LEU GLU ARG CYS ASP LEU GLU LEU GLU THR ASN GLY ARG SEQRES 3 A 694 ASP HIS HIS THR ALA ASP LEU CYS ARG GLU LYS LEU VAL SEQRES 4 A 694 VAL ARG ARG GLY GLN PRO PHE TRP LEU THR LEU HIS PHE SEQRES 5 A 694 GLU GLY ARG ASN TYR GLU ALA SER VAL ASP SER LEU THR SEQRES 6 A 694 PHE SER VAL VAL THR GLY PRO ALA PRO SER GLN GLU ALA SEQRES 7 A 694 GLY THR LYS ALA ARG PHE PRO LEU ARG ASP ALA VAL GLU SEQRES 8 A 694 GLU GLY ASP TRP THR ALA THR VAL VAL ASP GLN GLN ASP SEQRES 9 A 694 CYS THR LEU SER LEU GLN LEU THR THR PRO ALA ASN ALA SEQRES 10 A 694 PRO ILE GLY LEU TYR ARG LEU SER LEU GLU ALA SER THR SEQRES 11 A 694 GLY TYR GLN GLY SER SER PHE VAL LEU GLY HIS PHE ILE SEQRES 12 A 694 LEU LEU PHE ASN ALA TRP CYS PRO ALA ASP ALA VAL TYR SEQRES 13 A 694 LEU ASP SER GLU GLU GLU ARG GLN GLU TYR VAL LEU THR SEQRES 14 A 694 GLN GLN GLY PHE ILE TYR GLN GLY SER ALA LYS PHE ILE SEQRES 15 A 694 LYS ASN ILE PRO TRP ASN PHE GLY GLN PHE GLU ASP GLY SEQRES 16 A 694 ILE LEU ASP ILE CYS LEU ILE LEU LEU ASP VAL ASN PRO SEQRES 17 A 694 LYS PHE LEU LYS ASN ALA GLY ARG ASP CYS SER ARG ARG SEQRES 18 A 694 SER SER PRO VAL TYR VAL GLY ARG VAL VAL SER GLY MET SEQRES 19 A 694 VAL ASN CYS ASN ASP ASP GLN GLY VAL LEU LEU GLY ARG SEQRES 20 A 694 TRP ASP ASN ASN TYR GLY ASP GLY VAL SER PRO MET SER SEQRES 21 A 694 TRP ILE GLY SER VAL ASP ILE LEU ARG ARG TRP LYS ASN SEQRES 22 A 694 HIS GLY CYS GLN ARG VAL LYS TYR GLY GLN CYS TRP VAL SEQRES 23 A 694 PHE ALA ALA VAL ALA CYS THR VAL LEU ARG CYS LEU GLY SEQRES 24 A 694 ILE PRO THR ARG VAL VAL THR ASN TYR ASN SER ALA HIS SEQRES 25 A 694 ASP GLN ASN SER ASN LEU LEU ILE GLU TYR PHE ARG ASN SEQRES 26 A 694 GLU PHE GLY GLU ILE GLN GLY ASP LYS SER GLU MET ILE SEQRES 27 A 694 TRP ASN PHE HIS CYS TRP VAL GLU SER TRP MET THR ARG SEQRES 28 A 694 PRO ASP LEU GLN PRO GLY TYR GLU GLY TRP GLN ALA LEU SEQRES 29 A 694 ASP PRO THR PRO GLN GLU LYS SER GLU GLY THR TYR CYS SEQRES 30 A 694 CYS GLY PRO VAL PRO VAL ARG ALA ILE LYS GLU GLY ASP SEQRES 31 A 694 LEU SER THR LYS TYR ASP ALA PRO PHE VAL PHE ALA GLU SEQRES 32 A 694 VAL ASN ALA ASP VAL VAL ASP TRP ILE GLN GLN ASP ASP SEQRES 33 A 694 GLY SER VAL HIS LYS SER ILE ASN ARG SER LEU ILE VAL SEQRES 34 A 694 GLY LEU LYS ILE SER THR LYS SER VAL GLY ARG ASP GLU SEQRES 35 A 694 ARG GLU ASP ILE THR HIS THR TYR LYS TYR PRO GLU GLY SEQRES 36 A 694 SER SER GLU GLU ARG GLU ALA PHE THR ARG ALA ASN HIS SEQRES 37 A 694 LEU ASN LYS LEU ALA GLU LYS GLU GLU THR GLY MET ALA SEQRES 38 A 694 MET ARG ILE ARG VAL GLY GLN SER MET ASN MET GLY SER SEQRES 39 A 694 ASP PHE ASP VAL PHE ALA HIS ILE THR ASN ASN THR ALA SEQRES 40 A 694 GLU GLU TYR VAL CYS ARG LEU LEU LEU CYS ALA ARG THR SEQRES 41 A 694 VAL SER TYR ASN GLY ILE LEU GLY PRO GLU CYS GLY THR SEQRES 42 A 694 LYS TYR LEU LEU ASN LEU ASN LEU GLU PRO PHE SER GLU SEQRES 43 A 694 LYS SER VAL PRO LEU CYS ILE LEU TYR GLU LYS TYR ARG SEQRES 44 A 694 ASP CYS LEU THR GLU SER ASN LEU ILE LYS VAL ARG ALA SEQRES 45 A 694 LEU LEU VAL GLU PRO VAL ILE ASN SER TYR LEU LEU ALA SEQRES 46 A 694 GLU ARG ASP LEU TYR LEU GLU ASN PRO GLU ILE LYS ILE SEQRES 47 A 694 ARG ILE LEU GLY GLU PRO LYS GLN LYS ARG LYS LEU VAL SEQRES 48 A 694 ALA GLU VAL SER LEU GLN ASN PRO LEU PRO VAL ALA LEU SEQRES 49 A 694 GLU GLY CYS THR PHE THR VAL GLU GLY ALA GLY LEU THR SEQRES 50 A 694 GLU GLU GLN LYS THR VAL GLU ILE PRO ASP PRO VAL GLU SEQRES 51 A 694 ALA GLY GLU GLU VAL LYS VAL ARG MET ASP LEU LEU PRO SEQRES 52 A 694 LEU HIS MET GLY LEU HIS LYS LEU VAL VAL ASN PHE GLU SEQRES 53 A 694 SER ASP LYS LEU LYS ALA VAL LYS GLY PHE ARG ASN VAL SEQRES 54 A 694 ILE ILE GLY PRO ALA SEQRES 1 B 5 PHQ 02Y VAL PRO LEU MODRES 3S3J 02Y B 278 ALA 6-DIAZONIO-5-OXO-L-NORLEUCINE HET PHQ B 277 10 HET 02Y B 278 9 HET SO4 A 701 5 HET SO4 A 702 5 HET SO4 A 703 5 HET SO4 A 704 5 HET SO4 A 705 5 HET SO4 A 706 5 HET GOL A 707 6 HETNAM PHQ BENZYL CHLOROCARBONATE HETNAM 02Y 6-DIAZONIO-5-OXO-L-NORLEUCINE HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 PHQ C8 H7 CL O2 FORMUL 2 02Y C6 H10 N3 O3 1+ FORMUL 3 SO4 6(O4 S 2-) FORMUL 9 GOL C3 H8 O3 FORMUL 10 HOH *125(H2 O) HELIX 1 1 GLU A 13 HIS A 22 1 10 HELIX 2 2 THR A 23 CYS A 27 5 5 HELIX 3 3 SER A 152 VAL A 160 1 9 HELIX 4 4 GLY A 188 VAL A 199 1 12 HELIX 5 5 ASN A 200 ASN A 206 1 7 HELIX 6 6 ASN A 206 ARG A 214 1 9 HELIX 7 7 SER A 216 VAL A 228 1 13 HELIX 8 8 SER A 257 HIS A 267 1 11 HELIX 9 9 GLN A 276 GLY A 292 1 17 HELIX 10 10 ASN A 310 ASN A 318 1 9 HELIX 11 11 VAL A 376 GLY A 382 1 7 HELIX 12 12 ASP A 389 ASN A 398 1 10 HELIX 13 13 ILE A 439 LYS A 444 1 6 HELIX 14 14 SER A 449 ASN A 460 1 12 HELIX 15 15 LEU A 547 ARG A 552 1 6 SHEET 1 A 4 VAL A 6 ASP A 11 0 SHEET 2 A 4 PHE A 39 GLU A 46 -1 O GLU A 46 N VAL A 6 SHEET 3 A 4 THR A 99 THR A 105 -1 O LEU A 104 N PHE A 39 SHEET 4 A 4 THR A 89 GLN A 95 -1 N ASP A 94 O SER A 101 SHEET 1 B 5 LEU A 31 ARG A 34 0 SHEET 2 B 5 GLN A 126 LEU A 138 1 O ILE A 136 N VAL A 33 SHEET 3 B 5 GLY A 113 THR A 123 -1 N LEU A 117 O GLY A 133 SHEET 4 B 5 ASP A 55 THR A 63 -1 N THR A 58 O GLU A 120 SHEET 5 B 5 LYS A 74 PRO A 78 -1 O PHE A 77 N PHE A 59 SHEET 1 C 2 GLN A 164 GLY A 170 0 SHEET 2 C 2 ILE A 175 ASN A 181 -1 O LYS A 176 N GLN A 169 SHEET 1 D 2 LEU A 237 GLY A 239 0 SHEET 2 D 2 VAL A 272 GLY A 275 1 O VAL A 272 N LEU A 238 SHEET 1 E 6 VAL A 374 PRO A 375 0 SHEET 2 E 6 GLY A 353 LEU A 357 -1 N ALA A 356 O VAL A 374 SHEET 3 E 6 PHE A 334 MET A 342 -1 N VAL A 338 O LEU A 357 SHEET 4 E 6 THR A 295 ALA A 304 -1 N ASN A 300 O HIS A 335 SHEET 5 E 6 LEU A 420 LYS A 429 -1 O SER A 427 N THR A 299 SHEET 6 E 6 ARG A 436 ASP A 438 -1 O GLU A 437 N THR A 428 SHEET 1 F 6 SER A 415 ILE A 416 0 SHEET 2 F 6 ASP A 400 TRP A 404 -1 N ASP A 403 O SER A 415 SHEET 3 F 6 SER A 574 TYR A 583 1 O TYR A 575 N ASP A 400 SHEET 4 F 6 LEU A 560 GLU A 569 -1 N VAL A 563 O ARG A 580 SHEET 5 F 6 TYR A 503 VAL A 514 -1 N ARG A 512 O LYS A 562 SHEET 6 F 6 LEU A 520 LEU A 534 -1 O GLY A 521 N THR A 513 SHEET 1 G 3 MET A 473 ARG A 478 0 SHEET 2 G 3 PHE A 489 ASN A 497 -1 O PHE A 492 N ARG A 478 SHEET 3 G 3 SER A 538 ILE A 546 -1 O ILE A 546 N PHE A 489 SHEET 1 H 3 LYS A 590 LEU A 594 0 SHEET 2 H 3 LEU A 603 GLN A 610 -1 O GLU A 606 N ARG A 592 SHEET 3 H 3 GLU A 647 LEU A 654 -1 O LEU A 654 N LEU A 603 SHEET 1 I 4 LYS A 634 GLU A 637 0 SHEET 2 I 4 THR A 621 GLU A 625 -1 N VAL A 624 O LYS A 634 SHEET 3 I 4 HIS A 662 GLU A 669 -1 O ASN A 667 N THR A 623 SHEET 4 I 4 VAL A 676 VAL A 682 -1 O GLY A 678 N VAL A 666 LINK SG CYS A 277 C6 02Y B 278 1555 1555 1.75 LINK C1 PHQ B 277 N 02Y B 278 1555 1555 1.49 LINK C 02Y B 278 N VAL B 279 1555 1555 1.47 CISPEP 1 LYS A 273 TYR A 274 0 -0.88 CISPEP 2 GLY A 372 PRO A 373 0 3.34 CISPEP 3 LYS A 387 TYR A 388 0 1.87 SITE 1 AC1 2 LYS A 202 ARG A 222 SITE 1 AC2 4 LYS A 202 ARG A 209 ARG A 213 HOH A 833 SITE 1 AC3 1 ARG A 80 SITE 1 AC4 3 ARG A 80 ASP A 81 ALA A 82 SITE 1 AC5 5 ARG A 476 ARG A 478 VAL A 479 GLY A 480 SITE 2 AC5 5 ARG A 580 SITE 1 AC6 3 SER A 68 GLN A 69 LYS A 74 SITE 1 AC7 8 THR A 162 GLN A 164 LYS A 429 GLY A 432 SITE 2 AC7 8 ARG A 433 ASP A 434 LEU A 661 LYS A 663 SITE 1 AC8 18 GLN A 169 GLY A 170 LYS A 176 TRP A 241 SITE 2 AC8 18 MET A 252 GLN A 276 CYS A 277 ASN A 302 SITE 3 AC8 18 SER A 303 PHE A 316 MET A 330 ILE A 331 SITE 4 AC8 18 TRP A 332 ASN A 333 PHE A 334 TYR A 516 SITE 5 AC8 18 ASN A 517 HOH B 301 CRYST1 72.470 72.470 316.461 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013799 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013799 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003160 0.00000